Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 15, 2008Antimicrobial Agents and ChemotherapyOpen Access

Linezolid Alone or Combined with Rifampin against Methicillin-Resistant Staphylococcus aureus in Experimental Foreign-Body Infection

View Full Paper
Ask AI
Bookmark
Share

Authors

DBDaniela BaldoniMHManuel HaschkeZRZ. Rajacic

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Baldoni et al. (2008) studied this question.

synapsesocial.com/papers/6a5d8ef93ce08021578a7e2ehttps://doi.org/10.1128/aac.00775-08
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multiple Antibiotic–Resistant Bacteria in Long‐Term‐Care Facilities: An Emerging Problem in the Practice of Infectious Diseases2000 · 205 citations
  2. 2Impact of Bacterial Biofilm Formation on In Vitro and In Vivo Activities of Antibiotics1998 · 167 citations
  3. 3Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms2002 · 6,669 citations
  4. 4Antimicrobial Treatment of Orthopedic Implant-related Infections with Rifampin Combinations1992 · 253 citations
  5. 5In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods2003 · 136 citations